| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3860374 | The Journal of Urology | 2014 | 7 Pages |
Abstract
Bulkamid is not inferior to Contigen. It has a favorable, persistent effect on stress urinary incontinence with a low risk of serious adverse events. Bulkamid is a new, simple, office based bulking system that shows promise as a treatment in women with stress urinary incontinence, particularly since Contigen is no longer commercially available.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Eric R. Sokol, Mickey M. Karram, Roger Dmochowski,